Trailing-twelve-month (TTM) revenue is $11.71 Billion with a year-over-year growth of +0.45%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $3,519,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $2,664,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-19 |
| Q1 FY2026Period ended 2026-03-31 | $2,530,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-29 |
| Q2 FY2026Period ended 2026-06-30 | $2,998,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-29 |
| TTM revenue | $11,711,000,000 |
Current P/S: $3,953,372,025 market capitalization ÷ $11,711,000,000 TTM revenue = 0.34x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:10:15.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $3.00B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:11:11.156Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Avis | N/A | $4.9B | $6.5B | $6.8B | $6.8B | N/A |
| Budget | N/A | $3.7B | $4.7B |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Americas | $4.0B | $7.6B | $9.5B | $9.3B | $9.1B | $8.9B |
| Asia and Australasia | $310M | $356M | $593M | $647M |
$11.71B
$11.71 Billion
+0.45%
vs. $11.66B a year ago (TTM)
+12.05%
5 Year compound annual growth rate
1 Year
+0.45%
3 Year
(0.80%)
5 Year
+12.05%
10 Year
+3.12%
15 Year
+5.32%
20 Year
(2.15%)
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $11.65B | ($137.00M) | (1.16%) |
| 2024 | $11.79B | ($219.00M) | (1.82%) |
| 2023 | $12.01B | +$14.00M | +0.12% |
| 2022 | $11.99B | +$2.68B | +28.79% |
| 2021 | $9.31B | +$3.91B | +72.40% |
| 2020 |
TTM Growth
+0.45%
3-Year CAGR
(0.80%)
5-Year CAGR
+12.05%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:11:11.156Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $4.3B |
| N/A |
| International | $1.4B | N/A | N/A | N/A | N/A | N/A |
|---|
| Other Brands | N/A | $704M | $774M | $751M | $743M | N/A |
|---|
| Royalty | N/A | N/A | N/A | N/A | N/A | $202M |
|---|
| $635M |
| EMEA | N/A | $1.4B | $1.9B | $2.0B | $2.0B | $2.1B |
|---|
| Europe, Middle east, Africa | $1.1B | N/A | N/A | N/A | N/A | N/A |
|---|
| $5.40B |
| ($3.77B) |
| (41.10%) |
| 2019 | $9.17B | +$48.00M | +0.53% |
| 2018 | $9.12B | +$276.00M | +3.12% |
| 2017 | $8.85B | +$189.00M | +2.18% |
| 2016 | $8.66B | +$157.00M | +1.85% |
